Top 10 Companies in the Global Baicalein Market (2026): Market Leaders Shaping Herbal Innovation

The Global Baicalein Market was valued at USD 1.2 Billion in 2023 and is projected to reach USD 2.8 Billion by 2030, at a CAGR of 9.5% during the forecast period.

The USA market for Global Baicalein market is estimated to increase from USD 200 Million in 2023 to reach USD 450 Million by 2030, at a CAGR of 8.3% during the forecast period of 2023 through 2030.

The China market for Global Baicalein market is estimated to increase from USD 600 Million in 2023 to reach USD 1.4 Billion by 2030, at a CAGR of 10.1% during the forecast period of 2023 through 2030.

The Europe market for Global Baicalein market is estimated to increase from USD 150 Million in 2023 to reach USD 350 Million by 2030, at a CAGR of 7.7% during the forecast period of 2023 through 2030.

Report Overview
Baicalein (5,6,7-trihydroxyflavone) is a flavone, a type of flavonoid, originally isolated from the roots of Scutellaria baicalensis and Scutellaria lateriflora. It is also reported in Oroxylum indicum (Indian trumpetflower) and Thyme. It is the aglycone of baicalin. Baicalein is one of the active ingredients of Sho‑Saiko‑To, a Chinese herbal supplement believed to enhance liver health.
This report provides a deep insight into the global Baicalein market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Baicalein Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must‑read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Baicalein market in any manner.

Global Baicalein Market – View in Detailed Research Report

🔟 1. Kanghui Bio‑Technology

Headquarters: Guangzhou, China
Key Offering: High‑purity Baicalein, Baicalin derivatives, Herbal extract formulations

Kanghui has positioned itself as a leading supplier of Baicalein to pharmaceutical and nutraceutical companies. Its state‑of‑the‑art extraction process delivers 99% purity, meeting stringent regulatory standards for drug‑grade ingredients.

Sustainability & Growth Initiatives:

• Investment in renewable energy for extraction facilities
• Partnership with academic institutions for biosynthesis research
• Expansion into Southeast Asian markets through joint ventures

9️⃣ 2. Ciyuan Biotech

Headquarters: Beijing, China
Key Offering: Baicalein‑based nutraceuticals, functional foods

Ciyuan focuses on consumer‑direct products, leveraging Baicalein’s antioxidant profile to meet rising demand for natural wellness ingredients.

Sustainability & Growth Initiatives:

• Zero‑waste production protocols
• Development of a digital traceability platform for raw‑material sourcing
• Strategic acquisitions of boutique herbal extract producers

8️⃣ 3. Ginhall Biotech

Headquarters: Shanghai, China
Key Offering: Pharmaceutical‑grade Baicalein, formulation services

Ginhall’s expertise lies in tailoring Baicalein for specific therapeutic indications, such as hepatoprotective and anti‑inflammatory applications.

Sustainability & Growth Initiatives:

• Adoption of green chemistry principles in synthesis
• Collaboration with global pharma partners for co‑development
• R&D investment in synthetic biology to reduce raw‑material dependence

7️⃣ 4. Huakang Biotech Inc.

Headquarters: Chengdu, China
Key Offering: High‑purity Baicalein, herbal extract blends

Huakang’s portfolio targets both pharmaceutical and cosmetic applications, capitalizing on Baicalein’s skin‑rejuvenation properties.

Sustainability & Growth Initiatives:

• Carbon‑neutral manufacturing processes
• Community‑based cultivation of Scutellaria species
• Expansion of export channels to the Middle East and Africa

6️⃣ 5. Baiwei Biotechnology

Headquarters: Wuhan, China
Key Offering: Baicalein‑enriched functional foods, dietary supplements

Baiwei taps into the growing wellness segment, positioning Baicalein as a core ingredient in daily supplements.

Sustainability & Growth Initiatives:

• Smart agriculture systems for raw‑material cultivation
• Development of biodegradable packaging for supplements
• Strategic alliances with global nutraceutical distributors

5️⃣ 6. Senrui Biochemical

Headquarters: Shenzhen, China
Key Offering: Baicalein for cosmetics, pharmaceutical intermediates

Senrui has carved a niche in the cosmetic sector, leveraging Baicalein’s antioxidant activity to formulate anti‑aging products.

Sustainability & Growth Initiatives:

• Implementation of circular economy practices in production
• Partnership with eco‑friendly packaging firms
• Expansion into European beauty markets through licensing agreements

4️⃣ 7. Shandong Natural Medicine

Headquarters: Qingdao, China
Key Offering: Traditional herbal formulations containing Baicalein, clinical trial support

Shandong Natural Medicine bridges traditional Chinese medicine with modern clinical research, providing evidence‑based products for healthcare providers.

Sustainability & Growth Initiatives:

• Clinical validation of Baicalein efficacy through randomized trials
• Digital platform for patient‑reported outcomes
• Strategic expansion into ASEAN markets via joint ventures

3️⃣ 8. Hunan Biopharma

Headquarters: Changsha, China
Key Offering: Baicalein‑based drug candidates, vaccine adjuvants

Hunan Biopharma focuses on translational research, positioning Baicalein as an immunomodulatory agent in vaccine development.

Sustainability & Growth Initiatives:

• Partnerships with global vaccine developers for adjuvant trials
• Investment in bioreactor technology to scale production
• R&D pipeline expansion into oncology indications

2️⃣ 9. Jiangsu Bio‑Tech

Headquarters: Nanjing, China
Key Offering: Baicalein for pharmaceutical formulations, nutraceuticals

Jiangsu Bio‑Tech leverages its extensive distribution network to supply Baicalein to both domestic and international markets.

Sustainability & Growth Initiatives:

• Implementation of ISO 14001 environmental management system
• Digital supply‑chain transparency for traceability
• Expansion into European and African markets through strategic partnerships

1️⃣ 10. Guangzhou Bio

Headquarters: Guangzhou, China
Key Offering: High‑purity Baicalein, cosmetic ingredient blends

Guangzhou Bio capitalizes on the cosmetic demand for natural antioxidants, offering Baicalein formulations tailored for anti‑wrinkle products.

Sustainability & Growth Initiatives:

• Adoption of green extraction methods to reduce solvent use
• Collaboration with beauty tech firms for smart‑product development
• Expansion of e‑commerce platforms to reach global consumers

Download FREE Sample Report

Get Full Report

🌍 Outlook: The Future of Baicalein Is Rooted in Innovation

Baicalein’s trajectory is shaped by its dual role as a therapeutic agent and a natural ingredient for consumer products. The convergence of traditional medicine knowledge with modern biotechnological tools is creating new pathways for scalable production, while regulatory frameworks increasingly favor evidence‑based herbal ingredients.

📈 Key Trends Shaping the Market:

• Shift toward clinical‑grade herbal supplements backed by clinical data
• Expansion of Baicalein into personalized medicine, targeting specific genetic profiles
• Digitalization of supply chains, enabling real‑time traceability of raw materials
• Strategic alliances between biotechs and global pharma for co‑development of new drug candidates

📊 Future Trends: From Lab to Shelf

Emerging technologies such as CRISPR‑based biosynthesis and micro‑fermentation are poised to reduce production costs and increase yield. Meanwhile, consumer demand for clean‑label ingredients is pushing companies to adopt transparent sourcing and eco‑friendly manufacturing. Regulatory bodies in the EU and US are tightening approval pathways for botanical ingredients, making rigorous quality data a prerequisite for market entry.

In this evolving landscape, firms that blend scientific rigor with sustainable practices will likely secure the most favorable market positions.